Table 5.
Relationship of PFS1 to PFS2 by category
| PFS2 (mos) | |||||||
|---|---|---|---|---|---|---|---|
| PFS1 (mos) | 6-9 | 9-12 | 12-15 | 15-20 | >20 | Total | No. pts PFS2 > PFS1 (dur in mos) |
| 6-9 | 1 | 1 | 0 | 0 | 0 | 2 | 1 |
| 9-12 | 0 | 3 | 0 | 1 | 0 | 4 | 1 |
| 12-15 | 2 | 4 | 1 | 0 | 0 | 7 | 0 |
| 15-20 | 2 | 4 | 0 | 1 | 0 | 7 | 1 |
| >20 | 1 | 5 | 3 | 4 | 2 | 15 | 0 |
PFS1, the interval from the start of primary therapy to date of first relapse; PFS2, the interval from the start of secondary therapy to the date of the second relapse.